HomeInsights52 Week Low Stocks

Glaxosmithkline Consumer Healthcare Ltd(merged) 52 Week Low

Glaxosmithkline Consumer Healthcare Ltd(merged) 52 Week Low

stocks purchased

₹ 2.7 Cr

Volume Transacted

(Apr 15, 2020)

stocks purchased

2.5 K

Stocks Traded

(Apr 15, 2020)

Last Updated on: Dec 23, 2024

From Blinkx's GPT

No data available

Key Highlights

No data available

Company Fundamentals for GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

Market Price of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

1M

1Y

3Y

5Y

Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Apr 202010753.65
13 Apr 202010232.35
09 Apr 202010365.65
08 Apr 202010615.25
07 Apr 202010590.7
03 Apr 20209367.15
01 Apr 20209548.3
31 Mar 20209993.1
30 Mar 20209452.1
27 Mar 20209413.55

Asset Value vs Market Value of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

Historical Net Profit of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

No data available

* All values are in crore

GlaxoSmithkline Consumer Healthcare Ltd(Merged) News Hub

News

Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has ...

Read more

01 Apr 2020 12:47

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

17 Mar 2020 10:43

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

13 Jan 2020 16:32

News

GlaxoSmithkline Consumer Healthcare to announce Quarterly Result

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

15 Oct 2019 10:38

News

GlaxoSmithkline Consumer Healthcare Ltd up for third straight session

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stoc...

Read more

17 Sep 2019 13:05

News

GlaxoSmithkline Consumer Healthcare Ltd gains for third straight session

GlaxoSmithkline Consumer Healthcare Ltd gained for a third straight session today. The sto...

Read more

22 Aug 2019 13:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

Why is it important to track the 52-week low of GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks?

Investors should monitor the 52-week low of GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks hitting a 52-week low?

Factors leading to GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks when they hit a 52-week low?

Buying GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks?

Investors should monitor the 52-week low of GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock at their 52-week low?

An investor can analyze the reasons for the GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating GlaxoSmithkline Consumer Healthcare Ltd(Merged) stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence GlaxoSmithkline Consumer Healthcare Ltd(Merged) stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions